ResearcherUniversity of UdineActive in the last 2 years

Giovanni Gerardo Cardellino

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5077222725. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 13

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 3

Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional … Co-author DOI 10.1016/j.esmoop.2024.104001 ↗
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary a… Co-author DOI 10.1016/j.esmoop.2022.100777 ↗
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients. Last author DOI 10.1002/jcsm.12368 ↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Marina Macchini · 1 shared paper, 2025 · strength 0.19
- Paper Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Applica… DOI 10.1016/j.esmoop.2024.104001 ↗
Letizia Procaccio · 1 shared paper, 2025 · strength 0.19
- Paper Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Applica… DOI 10.1016/j.esmoop.2024.104001 ↗
Luigi Cavanna MD · 1 shared paper, 2025 · strength 0.19
- Paper Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Applica… DOI 10.1016/j.esmoop.2024.104001 ↗
Elisa Giommoni · 1 shared paper, 2025 · strength 0.19
- Paper Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Applica… DOI 10.1016/j.esmoop.2024.104001 ↗
Cidalia Maria de Sousa Pinto · 1 shared paper, 2025 · strength 0.19
- Paper Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Applica… DOI 10.1016/j.esmoop.2024.104001 ↗
Silvia Bozzarelli · 1 shared paper, 2025 · strength 0.19
- Paper Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Applica… DOI 10.1016/j.esmoop.2024.104001 ↗
Giulia Orsi · 1 shared paper, 2025 · strength 0.19
- Paper Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Applica… DOI 10.1016/j.esmoop.2024.104001 ↗
Michèle Milella · 1 shared paper, 2025 · strength 0.19
- Paper Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Applica… DOI 10.1016/j.esmoop.2024.104001 ↗
Michele Reni · 1 shared paper, 2025 · strength 0.19
- Paper Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Applica… DOI 10.1016/j.esmoop.2024.104001 ↗
Valentina Fanotto · 1 shared paper, 2019 · strength 0.07
- Paper The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients. DOI 10.1002/jcsm.12368 ↗
Fabio Puglisi · 1 shared paper, 2019 · strength 0.07
- Paper The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients. DOI 10.1002/jcsm.12368 ↗
Debora Basile · 1 shared paper, 2019 · strength 0.07
- Paper The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients. DOI 10.1002/jcsm.12368 ↗
Giuseppe Aprile · 1 shared paper, 2019 · strength 0.07
- Paper The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients. DOI 10.1002/jcsm.12368 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.